Center of Excellence of the European Union
 
Set page width to 800
Login
 
s1.jpg

Laszlo Buday

Dictionary
Publications
Publications

Articles

1.   Pesti S, Balázs A, Udupa R, Szabó B, Fekete A, B Gel G and Buday L (2012) [23181695]
  Complex formation of EphB1/Nck/Caskin1 leads to tyrosine phosphorylation and structural changes of the Caskin1 SH3 domain.
  Cell Commun Signal 10, 36
2.   Bögel G, Gujdár A, Geiszt M, Lányi Á, Fekete A, Sipeki S, Downward J and Buday L (2012) [22829589]
  Frank-ter Haar syndrome protein Tks4 regulates epidermal growth factor-dependent cell migration.
  J Biol Chem 287, 31321-9
3.   Buday L and Sipeki S (2011) [-100069893]
  Isoenzyme Selective Phosphoinositide 3-Kinase Inhibition: What do the Stones Kill?
  Curr Signal Transd T 6, 405-10
4.   Lányi A, Baráth M, Péterfi Z, Bőgel G, Orient A, Simon T, Petrovszki E, Kis-Tóth K, Sirokmány G, Rajnavölgyi E, Terhorst C, Buday L and Geiszt M (2011) [21886807]
  The Homolog of the Five SH3-Domain Protein (HOFI/SH3PXD2B) Regulates Lamellipodia Formation and Cell Spreading.
  PLoS ONE 6, e23653
5.   Krause-Gruszczynska M, Boehm M, Rohde M, Tegtmeyer N, Takahashi S, Buday L, Oyarzabal OA and Backert S (2011) [22204307]
  The signaling pathway of Campylobacter jejuni-induced Cdc42 activation: Role of fibronectin, integrin beta1, tyrosine kinases and guanine exchange factor Vav2.
  Cell Commun Signal 9, 32
6.   Buday L and Tompa P (2010) [21069901]
  Accessory proteins in signal transduction: scaffold proteins and beyond.
  FEBS J 277, 4347
7.   Radnai L, Rapali P, Hódi Z, Süveges D, Molnár T, Kiss B, Bécsi B, Erdödi F, Buday L, Kardos J, Kovács M and Nyitray L (2010) [20889982]
  Affinity, avidity, and kinetics of target sequence binding to LC8 dynein light chain isoforms.
  J Biol Chem 285, 38649-57
8.   Szekeres M, Nádasy GL, Turu G, Süpeki K, Szidonya L, Buday L, Chaplin T, Clark AJ and Hunyady L (2010) [20181798]
  Angiotensin II-induced expression of brain-derived neurotrophic factor in human and rat adrenocortical cells.
  Endocrinology 151, 1695-703
9.   Buday L and Tompa P (2010) [20883491]
  Functional classification of scaffold proteins and related molecules.
  FEBS J 277, 4348-55
10.   Borbély G, Szabadkai I, Horváth Z, Markó P, Varga Z, Breza N, Baska F, Vántus T, Huszár M, Geiszt M, Hunyady L, Buday L, Orfi L and Kéri G (2010) [20731357]
  Small-molecule inhibitors of NADPH oxidase 4.
  J Med Chem 53, 6758-62
11.   de Boussac H, Ratajewski M, Sachrajda I, Köblös G, Tordai A, Pulaski L, Buday L, Váradi A and Arányi T (2010) [20463007]
  The ERK1/2-hepatocyte nuclear factor 4alpha axis regulates human ABCC6 gene expression in hepatocytes.
  J Biol Chem 285, 22800-8
12.   Donkó A, Orient A, Szabó PT, Németh G, Vántus T, Kéri G, Orfi L, Hunyady L, Buday L and Geiszt M (2009) [19340621]
  Detection of hydrogen peroxide by lactoperoxidase-mediated dityrosine formation.
  Free Radical Res 43, 440-5
13.   Balázs A, Csizmok V, Buday L, Rakács M, Kiss R, Bokor M, Udupa R, Tompa K and Tompa P (2009) [19523119]
  High levels of structural disorder in scaffold proteins as exemplified by a novel neuronal protein, CASK-interactive protein1.
  FEBS J 276, 3744-56
14.   Hegyi H, Buday L and Tompa P (2009) [19888473]
  Intrinsic structural disorder confers cellular viability on oncogenic fusion proteins.
  PLoS Comput Biol 5, e1000552
15.   Oh MA, Choi S, Lee MJ, Choi MC, Lee SA, Ko W, Cance WG, Oh ES, Buday L, Kim SH and Lee JW (2009) [19339212]
  Specific tyrosine phosphorylation of focal adhesion kinase mediated by Fer tyrosine kinase in suspended hepatocytes.
  Bba-mol Cell Res 1793, 781-91
16.   Buday L and Downward J (2008) [18541156]
  Many faces of Ras activation.
  Bba-rev Cancer 1786, 178-87
17.   Buday L and Downward J (2007) [17292556]
  Roles of cortactin in tumor pathogenesis.
  Bba-rev Cancer 1775, 263-73
18.   Illés A, Enyedi B, Tamás P, Balázs A, Bogel G, Melinda , Lukács and Buday L (2006) [16364453]
  Cortactin is required for integrin-mediated cell spreading.
  Immunol Lett 104, 124-30
19.   Turu G, Szidonya L, Gáborik Z, Buday L, Spät A, Clark AJ and Hunyady L (2006) [16359671]
  Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors.
  FEBS Lett 580, 41-5
20.   Illés A, Enyedi B, Tamás P, Balázs A, Bogel G and Buday L (2006) [16109479]
  Inducible phosphorylation of cortactin is not necessary for cortactin-mediated actin polymerisation.
  Cell Signal 18, 830-40
21.   Elkind NB, Szentpétery Z, Apáti A, Ozvegy-Laczka C, Várady G, Ujhelly O, Szabó K, Homolya L, Váradi A, Buday L, Kéri G, Német K and Sarkadi B (2005) [15753373]
  Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).
  Cancer Res 65, 1770-7
22.   Várnai P, Bondeva T, Tamás P, Tóth B, Buday L, Hunyady L and Balla T (2005) [16219693]
  Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners.
  J Cell Sci 118, 4879-88
23.   Tompa P, Szász C and Buday L (2005) [16054818]
  Structural disorder throws new light on moonlighting.
  Trends Biochem Sci 30, 484-9
24.   Gujdár A, Sipeki S, Bander E, Buday L and Faragó A (2004) [14709339]
  Protein kinase C modulates negatively the hepatocyte growth factor-induced migration, integrin expression and phosphatidylinositol 3-kinase activation.
  Cell Signal 16, 505-13
25.   Tamás P, Solti Z, Bauer P, Illés A, Sipeki S, Bauer A, Faragó A, Downward J and Buday L (2003) [12454019]
  Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac.
  J Biol Chem 278, 5163-71
26.   Gujdár A, Sipeki S, Bander E, Buday L and Faragó A (2003) [12531429]
  Phorbol ester-induced migration of HepG2 cells is accompanied by intensive stress fibre formation, enhanced integrin expression and transient down-regulation of p21-activated kinase 1.
  Cell Signal 15, 307-18
27.   Buday L, Wunderlich L and Tamás P (2002) [12034353]
  The Nck family of adapter proteins: regulators of actin cytoskeleton.
  Cell Signal 14, 723-31
28.   Tamás P, Solti Z and Buday L (2001) [11516622]
  Membrane-targeting is critical for the phosphorylation of Vav2 by activated EGF receptor.
  Cell Signal 13, 475-81
29.   Wunderlich L, Faragó A, Downward J and Buday L (1999) [10229072]
  Association of Nck with tyrosine-phosphorylated SLP-76 in activated T lymphocytes.
  Eur J Immunol 29, 1068-75
30.   Wunderlich L, Faragó A and Buday L (1999) [10206341]
  Characterization of interactions of Nck with Sos and dynamin.
  Cell Signal 11, 25-9
31.   Buday L (1999) [10393272]
  Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins.
  Biochimica Et Biophysica Acta-reviews On Biomembranes 1422, 187-204
32.   Sipeki S, Bander E, Buday L, Farkas G, Bácsy E, Ways DK and Faragó A (1999) [10659996]
  Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering.
  Cell Signal 11, 885-90
33.   Wunderlich L, Gohér A, Faragó A, Downward J and Buday L (1999) [10372803]
  Requirement of multiple SH3 domains of Nck for ligand binding.
  Cell Signal 11, 253-62
34.   Mócsai A, Bánfi B, Kapus A, Farkas G, Geiszt M, Buday L, Faragó A and Ligeti E (1997) [9353132]
  Differential effects of tyrosine kinase inhibitors and an inhibitor of the mitogen-activated protein kinase cascade on degranulation and superoxide production of human neutrophil granulocytes.
  Biochem Pharmacol 54, 781-9
35.   Szászi K, Buday L and Kapus A (1997) [9195983]
  Shrinkage-induced protein tyrosine phosphorylation in Chinese hamster ovary cells.
  J Biol Chem 272, 16670-8
36.   Buday L, Khwaja A, Sipeki S, Faragó A and Downward J (1996) [8626404]
  Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation.
  J Biol Chem 271, 6159-63
37.   Buday L, Warne PH and Downward J (1995) [7478553]
  Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos.
  Oncogene 11, 1327-31
38.   Buday L, Egan SE, Rodriguez Viciana P, Cantrell DA and Downward J (1994) [7510700]
  A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells.
  J Biol Chem 269, 9019-23
39.   Pronk GJ, de Vries-Smits AM, Buday L, Downward J, Maassen JA, Medema RH and Bos JL (1994) [8114695]
  Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.
  Mol Cell Biol 14, 1575-81
40.   Farkas G, Buday L, Csermely P and Faragó A (1994) [8305505]
  Lipocortin I is not accessible for protein kinase C bound to the cytoplasmic surface of the plasma membrane in streptolysin-O-permeabilized pig granulocytes.
  Biochim Biophys Acta 1220, 315-22
41.   Reif K, Buday L, Downward J and Cantrell DA (1994) [8188688]
  SH3 domains of the adapter molecule Grb2 complex with two proteins in T cells: the guanine nucleotide exchange protein Sos and a 75-kDa protein that is a substrate for T cell antigen receptor-activated tyrosine kinases.
  J Biol Chem 269, 14081-7
42.   Buday L (1994) [7824256]
  [Oncogenes and tumor suppressor genes in the signal transduction pathways of growth factors]
  Orv Hetil 135, 2579-84
43.   Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM and Weinberg RA (1993) [8479536]
  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation.
  Nature 363, 45-51
44.   Buday L and Downward J (1993) [8490966]
  Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.
  Cell 73, 611-20
45.   Buday L and Downward J (1993) [8441421]
  Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts.
  Mol Cell Biol 13, 1903-10
46.   Bauer PI, Farkas G, Buday L, Mikala G, Meszaros G, Kun E and Farago A (1992) [1530631]
  Inhibition of DNA binding by the phosphorylation of poly ADP-ribose polymerase protein catalysed by protein kinase C.
  Biochem Bioph Res Co 187, 730-6
47.   Buday L, Farkas G and Faragó A (1992) [1592153]
  Synthetic oligopeptide substrates which fail to compete with H1 histone for type II and type III isoenzymes of protein kinase C.
  Int J Biochem. 24, 777-82
48.   Hajnóczky G, Várnai P, Buday L, Faragó A and Spät A (1992) [1547736]
  The role of protein kinase-C in control of aldosterone production by rat adrenal glomerulosa cells: activation of protein kinase-C by stimulation with potassium.
  Endocrinology 130, 2230-6
49.   Farkas G, Buday L, Antoni F and Faragó A (1991) [1995069]
  The 38 kDa Ca2+/membrane-binding protein of pig granulocytes needs a high Ca2+ concentration to be phosphorylated by protein kinase C.
  Biochim Biophys Acta 1091, 81-6
50.   Buday L and Faragó A (1990) [2125008]
  Dual effect of arachidonic acid on protein kinase C isoenzymes isolated from rabbit thymus cells.
  FEBS Lett 276, 223-6
51.   Faragó A, Farkas G, Mészáros G, Buday L, Antoni F and Seprödi J (1989) [2917653]
  Isoenzyme patterns of protein kinase C and a phospholipid-dependent but Ca2+-inhibited enzyme fraction in the crude extracts of different tissues.
  FEBS Lett 243, 328-32
52.   Buday L, Farkas G and Faragó A (1989) [2532838]
  The dominant substrate of protein kinase C in the extracts of pig granulocytes is a 38 kDa Ca2+/membrane binding protein.
  Acta Biochim Biophys Acad Sci Hung 24, 101-6
53.   Buday L, Mészáros G, Farkas G, Seprödi J, Antoni F and Faragó A (1989) [2544454]
  Two components of type III protein kinase C with different substrate specificities and a phospholipid-dependent but Ca2+-inhibited protein kinase in rat brain.
  FEBS Lett 249, 324-8
54.   Buday L, Seprödi J, Farkas G, Mészáros G, Romhányi T, Bánhegyi G, Mandl J, Antoni F and Faragó A (1987) [3666136]
  Proteolytic activation of protein kinase C in the extracts of cells treated for a short time with phorbol ester.
  FEBS Lett 223, 15-9
55.   Romhányi T, Seprödi J, Antoni F, Mészáros G, Buday L and Faragó A (1986) [3019424]
  The assay of the activity of protein kinase C with the synthetic oligopeptide substrate designed for histone kinase II.
  Biochim Biophys Acta 888, 325-31